Chemical, pharmacodynamic and pharmacokinetic characterization of the GluN2B receptor antagonist 3-(4-phenylbutyl),2,3,4,5-tetrahydro-1H-3-benzazepine-1,7-diol – starting point for PET tracer development.

M. Korff, R. Steigerwald, E. Bechthold, D. Schepmann, J. A. Schreiber, S. G. Meuth, G. Seebohm, B. Wünsch

Research article (journal) | Peer reviewed

Details about the publication

JournalBiological Chemistry
Volume404
Issue4
Page range279-289
StatusPublished
Release year2023
Language in which the publication is writtenEnglish
DOI10.1515/hsz-2022-0222
Keywordspharmacodynamic; pharmacokinetic; characterization; GluN2B receptor antagonist; PET tracer

Authors from the University of Münster

Wünsch, Bernhard
Professur für Pharmazeutische Chemie (Prof. Wünsch)